Swiss speciality chemicals giant Clariant will be developing a new healthcare packaging manufacturing facility at Cuddalore, Tamil Nadu, India.
The firm intends to invest around Sfr10m ($9.7m) for the proposed facility, which is expected to expand its presence in the country’s growing pharmaceutical packaging market.
Go deeper with GlobalData
The plant will be initially used to manufacture desiccant canisters and packets, which are used by the pharmaceutical industry as moisture control products.
The products are inserted into pharmaceutical packaging to control moisture and protect stability of the medicines, ensuring a longer shelf life.
Desiccants produced at the facility will be in compliance with the relevant cGMP and US FDA regulations, and will be supplied to the globally active generic and branded pharmaceutical firms operating in India, as well as the domestic pharmaceutical market.
See Also:
Clariant said: "The desiccant production area will be Clean Room Class 100,000 and certified ISO 8."
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataClariant India region president Deepak Parikh said: "This new manufacturing facility is in alignment with our overall growth strategy in the country. The new facility will enable us to enhance our medical specialities business and offer end-to-end solutions to our existing, as well as potential customers.
"Clariant in India is accelerating change and continues to fulfil our commitments to all our stakeholders, as the Indian market stays at the core of Clariant’s global focus."
Clariant masterbatches senior vice-president and general manager Marco Cenisio said: "The significant investment in Cuddalore of our new healthcare packaging plant further strengthens our commitment to capture the growth opportunities that exist in emerging markets and specifically in the highly attractive market in India.
"It also highlights the commitment of our business unit to devote a large portion of the capital budget to our healthcare packaging business to continue to fund its growth."
The firm’s healthcare packaging unit has recently formed partnership with FreeThink Technologies to offer predictive calculation and modeling for the stability of drugs to its pharmaceutical and nutraceutical customers.
Image: The proposed plant will initially produce moisture control products for Indian pharmaceutical packaging market. Photo: courtesy of holohololand via FreeDigitalPhotos.net.
